What is the current unmet need for CV risk reduction, in general, beyond LDL-C level lowering?

What is the current unmet need for CV risk reduction, in general, beyond LDL-C level lowering?

What is the current unmet need for CV risk reduction, in general, beyond LDL-C level lowering?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical and Preventive Cardiologist's Perspective

Presenter

Dan Atar, MD

Dan Atar, MD

Head of Research Oslo University Hospital Ulleval Professor of Cardiology University of Oslo Oslo, Norway Visiting Associate Professorship Johns Hopkins University Baltimore, Maryland